7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

ABIVAX Société Anonyme
(NASDAQ:ABVX) 

ABVX stock logo

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. The company is evaluating its lead drug candidate, obefazimod, in P...

Founded: 2013
IPO Price: $11.6 (Oct 20, 2023)
Sector: TECHNOLOGY
Industry: GENERAL

Share this website to your friends
ABIVAX Société Anonyme Days Payable Outstanding ttm (DPO)
202311 202312 202401 202402 202403 202404 024.9449.8874.8399.77124.71149.65174.6Thousand
ABIVAX Société Anonyme Op Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -1.91-1.64-1.37-1.09-0.82-0.55-0.270
ABIVAX Société Anonyme Free Cashflow Per Share ttm
202311 202312 202401 202402 202403 202404 -2.03-1.74-1.45-1.16-0.87-0.58-0.290
ABIVAX Société Anonyme Cash Per Share ttm
202311 202312 202401 202402 202403 202404 00.731.472.22.933.664.45.13
ABIVAX Société Anonyme (GAAP) P/E ratio ttm
202311 202312 202401 202402 202403 202404 -4.44-3.8-3.17-2.54-1.9-1.27-0.630
ABIVAX Société Anonyme P/B ratio ttm
202311 202312 202401 202402 202403 202404 05.0910.1815.2720.3625.4430.5335.62
No extra charts and metrics for this ticker.